RESMED INC
RESMED INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1,661 | 1,417 | 1,384 | 1,209 | 933 | 522 | 426 | 238 | 238 | 210 | 209 | 228 | |||||
Accounts Receivable Net Current | 999 | 986 | 907 | 939 | 908 | 860 | 811 | 837 | 779 | 730 | 692 | 705 | |||||
Inventory Net | 912 | 922 | 946 | 928 | 863 | 882 | 918 | 822 | 829 | 933 | 958 | 998 | |||||
Prepaid Expense And Other Assets Current | 493 | 494 | 389 | 429 | 505 | 572 | 486 | 460 | 505 | 505 | 445 | 437 | |||||
Assets Current | 4,064 | 3,819 | 3,626 | 3,506 | 3,208 | 2,836 | 2,641 | 2,358 | 2,351 | 2,378 | 2,305 | 2,368 | |||||
Assets Noncurrent | |||||||||||||||||
Property Plant And Equipment Net | 567 | 564 | 564 | 551 | 535 | 520 | 560 | 548 | 540 | 552 | 534 | 538 | |||||
Operating Lease Right Of Use Asset | 162 | 166 | 162 | 167 | 153 | 151 | 157 | 151 | 147 | 153 | 123 | 128 | |||||
Goodwill | 3,043 | 3,044 | 3,044 | 3,047 | 2,849 | 2,805 | 2,886 | 2,842 | 2,836 | 2,862 | 2,812 | 2,770 | |||||
Finite Lived Intangible Assets Net | 425 | 430 | 447 | 465 | 430 | 438 | 479 | 486 | 501 | 528 | 563 | 552 | |||||
Deferred Income Taxes And Other Assets Noncurrent | 313 | 286 | 276 | 253 | 217 | 209 | 221 | 204 | 162 | 156 | 138 | 133 | |||||
Other Assets Noncurrent | 211 | 194 | 190 | 186 | 175 | 181 | 279 | 284 | 277 | 276 | 265 | 262 | |||||
Assets Noncurrent | 4,720 | 4,685 | 4,683 | 4,669 | 4,358 | 4,305 | 4,581 | 4,515 | 4,463 | 4,527 | 4,436 | 4,384 | |||||
Assets | 8,784 | 8,503 | 8,308 | 8,174 | 7,567 | 7,141 | 7,222 | 6,872 | 6,815 | 6,905 | 6,741 | 6,752 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 273 | 250 | 267 | 278 | 223 | 220 | 249 | 238 | 177 | 202 | 177 | 151 | |||||
Accrued Liabilities Current | 446 | 392 | 396 | 402 | 386 | 353 | 366 | 378 | 356 | 332 | 348 | 366 | |||||
Operating Lease Liability Current | 29 | 30 | 30 | 31 | 29 | 28 | 28 | 25 | 24 | 24 | 22 | 22 | |||||
Contract With Customer Liability Current | 179 | 176 | 168 | 166 | 160 | 157 | 157 | 153 | 151 | 149 | 147 | 138 | |||||
Accrued Income Taxes Current | 163 | 140 | 135 | 132 | 133 | 85 | 94 | 108 | 55 | 47 | 67 | 72 | |||||
Short Term Borrowings | 260 | 260 | 260 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Liabilities Current | 1,351 | 1,248 | 1,256 | 1,019 | 941 | 852 | 904 | 911 | 773 | 764 | 771 | 759 | |||||
Liabilities Noncurrent | |||||||||||||||||
Contract With Customer Liability Noncurrent | 163 | 160 | 159 | 157 | 151 | 147 | 144 | 137 | 132 | 127 | 121 | 119 | |||||
Deferred Income Taxes And Other Tax Liabilities No… | 78 | 78 | 78 | 78 | 79 | 77 | 84 | 79 | 87 | 89 | 88 | 91 | |||||
Operating Lease Liability Noncurrent | 150 | 154 | 148 | 153 | 138 | 139 | 144 | 141 | 136 | 141 | 112 | 117 | |||||
Other Liabilities Noncurrent | 146 | 139 | 138 | 142 | 49 | 11 | 83 | 42 | 48 | 73 | 34 | 68 | |||||
Long Term Debt | 404 | 404 | 409 | 658 | 663 | 663 | 668 | 697 | 997 | 1,217 | 1,352 | 1,431 | |||||
Accrued Income Taxes Noncurrent | - | - | - | 0 | - | - | - | 0 | 12 | 12 | 12 | 37 | |||||
Liabilities Noncurrent | 941 | 934 | 932 | 1,187 | 1,080 | 1,036 | 1,123 | 1,098 | 1,412 | 1,659 | 1,720 | 1,863 | |||||
Liabilities | 2,292 | 2,182 | 2,187 | 2,207 | 2,021 | 1,888 | 2,027 | 2,008 | 2,185 | 2,423 | 2,490 | 2,622 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value Outstanding | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Additional Paid In Capital Common Stock | 2,134 | 2,103 | 2,062 | 2,034 | 1,990 | 1,957 | 1,925 | 1,897 | 1,848 | 1,823 | 1,791 | 1,772 | |||||
Retained Earnings Accumulated Deficit | 6,959 | 6,647 | 6,342 | 6,081 | 5,779 | 5,492 | 5,225 | 4,992 | 4,770 | 4,540 | 4,402 | 4,253 | |||||
Treasury Stock Common Value | -2,577 | -2,400 | -2,223 | -2,073 | -1,973 | -1,898 | -1,823 | -1,773 | -1,723 | -1,673 | -1,623 | -1,623 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -25 | -30 | -61 | -75 | -251 | -299 | -132 | -252 | -265 | -208 | -320 | -273 | |||||
Stockholders Equity | 6,492 | 6,321 | 6,121 | 5,968 | 5,546 | 5,253 | 5,195 | 4,864 | 4,630 | 4,482 | 4,250 | 4,130 | |||||
Liabilities And Stockholders Equity | 8,784 | 8,503 | 8,308 | 8,174 | 7,567 | 7,141 | 7,222 | 6,872 | 6,815 | 6,905 | 6,741 | 6,752 | |||||
Allowance For Doubtful Accounts Receivable Current | 29 | 29 | 25 | 22 | 20 | 21 | 24 | 21 | 20 | 22 | 21 | 24 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | |||||
Common Stock Shares Authorized | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | |||||
Common Stock Shares Issued | 191 | 191 | 190 | 190 | 190 | 190 | 190 | 190 | 189 | 189 | 189 | 189 | |||||
Shares Outstanding | 145 | 146 | 146 | 146 | 147 | 147 | 147 | 147 | 147 | 147 | 147 | 147 | |||||
Treasury Stock Common Shares | 46 | 45 | 44 | 44 | 44 | 43 | 43 | 43 | 42 | 42 | 42 | 42 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.81% | -0.55% | 4.58% | 0.55% | -12.31% | -11.48% | 1.78% | -7.72% | -2.65% | - | - | - |
| 2025 | -8.13% | -6.65% | -8.49% | -1.68% | -6.77% | -9.65% | 6.83% | 5.84% | 7.98% | -3.11% | -4.60% | -8.41% |
| 2024 | 10.97% | 25.95% | 29.56% | -2.92% | 2.24% | -0.01% | 0.46% | -2.69% | -5.86% | 13.40% | 10.61% | 18.51% |
| 2023 | - | - | - | - | - | - | - | - | - | -11.07% | -17.39% | -24.78% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.01 | 3.06 | 2.89 | 3.44 | 3.41 | 3.33 | 2.92 | 2.59 | 3.04 | 3.11 | 2.99 | 3.12 | |||||
| Quick Ratio | 1.97 | 1.93 | 1.82 | 2.11 | 1.96 | 1.62 | 1.37 | 1.18 | 1.32 | 1.23 | 1.17 | 1.23 | |||||
| Working Capital | 2.71B | 2.57B | 2.37B | 2.49B | 2.27B | 1.98B | 1.74B | 1.45B | 1.58B | 1.61B | 1.53B | 1.61B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.35 | 0.35 | 0.36 | 0.37 | 0.36 | 0.36 | 0.39 | 0.41 | 0.47 | 0.54 | 0.59 | 0.63 | |||||
| Interest Coverage TTM | 54.41 | 78.10 | 108.24 | 187.55 | 176.20 | 80.51 | 43.76 | 28.88 | 22.18 | 19.43 | 20.74 | 23.89 | |||||
| Debt Ratio | 0.26 | 0.26 | 0.26 | 0.27 | 0.27 | 0.26 | 0.28 | 0.29 | 0.32 | 0.35 | 0.37 | 0.39 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.68 | 0.69 | 0.68 | 0.68 | 0.70 | 0.70 | 0.69 | 0.69 | 0.68 | 0.66 | 0.73 | 0.71 | |||||
| Days Sales Outstanding TTM | 62.83 | 62.40 | 59.65 | 63.01 | 61.31 | 58.89 | 57.08 | 60.07 | 58.34 | 56.81 | 54.77 | 55.35 | |||||
| Receivables Turnover TTM | 5.81 | 5.85 | 6.12 | 5.79 | 5.95 | 6.20 | 6.39 | 6.08 | 6.26 | 6.43 | 6.66 | 6.59 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 10.43 | 10.15 | 9.79 | 9.51 | 8.92 | 8.47 | 7.54 | 6.92 | 6.50 | 6.03 | 6.15 | 6.09 | |||||
| Free Cash Flow Per Share TTM | 12.07 | 12.28 | 12.10 | 11.33 | 10.69 | 9.48 | 9.21 | 8.85 | 7.41 | 6.54 | 5.54 | 3.91 | |||||
| Dividend Per Share TTM | 2.34 | 2.27 | 2.19 | 2.12 | 2.07 | 2.02 | 1.97 | 1.92 | 1.88 | 1.84 | 1.80 | 1.76 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 61.59% | 60.87% | 60.08% | 59.36% | 58.76% | 58.39% | 57.67% | 56.67% | 55.78% | 55.11% | 55.20% | 55.78% | |||||
| Operating Profit Margin TTM | 34.18% | 33.70% | 33.18% | 32.75% | 32.10% | 31.67% | 29.50% | 28.17% | 26.48% | 25.31% | 26.17% | 26.80% | |||||
| Net Profit Margin TTM | 27.44% | 27.53% | 27.35% | 27.22% | 26.15% | 25.35% | 23.15% | 21.79% | 20.91% | 19.77% | 20.72% | 21.25% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 10.28% | 9.57% | 9.36% | 9.84% | 9.54% | 9.38% | 9.88% | 10.95% | 14.16% | 19.69% | 20.71% | 18.02% | |||||
| Net Income Growth (1Y) | 15.71% | 18.99% | 29.21% | 37.20% | 37.03% | 40.24% | 22.77% | 13.75% | 11.06% | 10.00% | 15.29% | 15.15% | |||||
| EPS Growth (1Y) | 16.81% | 19.78% | 29.81% | 37.48% | 37.25% | 40.55% | 22.95% | 13.55% | 11.02% | 9.68% | 14.78% | 14.61% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 21.41 | 23.52 | 27.62 | 26.76 | 24.71 | 26.51 | 31.69 | 27.05 | 29.74 | 27.77 | 23.36 | 34.70 | |||||
| P/B TTM | 5.01 | 5.53 | 6.49 | 6.28 | 5.85 | 6.30 | 6.79 | 5.68 | 6.16 | 5.52 | 4.98 | 7.54 | |||||
| P/S TTM | 5.87 | 6.47 | 7.55 | 7.28 | 6.46 | 6.72 | 7.34 | 5.90 | 6.22 | 5.49 | 4.84 | 7.37 | |||||
| Market Cap | 32.53B | 34.94B | 39.71B | 37.49B | 32.45B | 33.10B | 35.27B | 27.62B | 28.50B | 24.72B | 21.18B | 31.14B | |||||
| Enterprise Value | 31.53B | 34.19B | 38.99B | 36.94B | 32.19B | 33.25B | 35.52B | 28.09B | 29.27B | 25.74B | 22.33B | 32.36B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 1.75B | 1.79B | 1.77B | 1.66B | 1.57B | 1.39B | 1.35B | 1.30B | 1.09B | 962.46M | 814.27M | 573.63M | |||||
| Net Debt | -996.42M | -753.24M | -715.29M | -541.16M | -259.68M | 150.82M | 251.11M | 468.85M | 769.04M | 1.02B | 1.15B | 1.21B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
RESMED INC (RMD) — SEC Financial Statements & Analysis
RESMED INC (RMD) is a surgical & medical instruments & apparatus company, incorporated in DE. RESMED INC trades on RSMDF: OTC as: RMD: NYSE. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), RESMED INC reported a 10.28% year-over-year revenue growth, a Gross Profit Margin of 61.59% (TTM), a Debt-to-Equity ratio of 0.35x, a Price-to-Sales (P/S) ratio of 5.87x (TTM), a Price-to-Book (P/B) ratio of 5.01 (TTM), at a market cap of $32.53B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 10.28%
- Gross Profit Margin TTM
- 61.59%
- Debt To Equity
- 0.35x
- P/S TTM
- 5.87x
- P/B TTM
- 5.01
- Market Cap
- $32.53B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is RESMED INC in?
RESMED INC (RMD) operates in the Surgical & Medical Instruments & Apparatus industry.
What is RMD's market cap?
RESMED INC (RMD) has a market capitalization of $32.53B as of 2026-03-31.
What is RMD's P/E ratio?
RESMED INC (RMD)'s trailing twelve month P/E ratio is 21.41x as of 2026-03-31.
What exchange does RMD trade on?
RESMED INC (RMD) trades on the RSMDF: OTC.
Where is RESMED INC incorporated?
RESMED INC is incorporated in DE.